Relationship between expression of immune inflammationindicators and abnormal glucose as well as lipid metabolism in patients with recurrent schizophrenia

WANG Xiaoyu; PAN Shujuan; GUO Liyuan; WANG Jing

doi:10.7619/jcmp.20211417

Journal of Clinical Medicine in Practice > 2021 > 25(19): 101-106. > DOI: 10.7619/jcmp.20211417

WANG Xiaoyu, PAN Shujuan, GUO Liyuan, WANG Jing. Relationship between expression of immune inflammationindicators and abnormal glucose as well as lipid metabolism in patients with recurrent schizophrenia[J]. Journal of Clinical Medicine in Practice, 2021, 25(19): 101-106. DOI: 10.7619/jcmp.20211417

Citation:

PDF (719 KB)

Relationship between expression of immune inflammationindicators and abnormal glucose as well as lipid metabolism in patients with recurrent schizophrenia

1.
Institute of Psychology, Institute of Psychology of Chinese Academy of Sciences, University of Chinese Academy of Sciences, Beijing, 100101
2.
Beijing Huilongguan Hospital, Huilongguan Clinical Medical School of Peking University, Beijing, 100096

More Information

Received Date: March 30, 2021
Available Online: October 27, 2021
Published Date: October 14, 2021

Graphical Abstract

Abstract

Abstract

Objective To investigate the expressions of immune inflammation indicators, such as the neutrophil-to-lymphocyte ratio (NLR), high sensitivity C-reactive protein (hs-CRP), homocysteine (Hcy), red blood cell distribution width (RDW) and antinuclear antibody (ANA) in patients with recurrent schizophrenia, and their relationships with abnormal glucose and lipid metabolism.
Methods A total of 70 patients with recurrent schizophrenia were selected as case group, and 48 healthy subjects were selected as control group. The expressions of NLR, RDW, hs-CRP, Hcy and ANA were compared in two groups. A total of 33 patients who were treated with first-line second generation antipsychotics for 1 month were selected from the case group, and the expressions of NLR, RDW, hs-CRP and Hcy before and after treatment were compared. The univariate and multivariate binary Logistic regression analysis were used to analyze the relationships between the immune inflammatory indicators such as NLR, RDW, hs-CRP, Hcy and the abnormal glucose as well as lipid metabolism in patients in the case group.
Results The NLR, RDW, hs-CRP and Hcy in the case group were significantly higher than those in the control group at admission(P < 0.05). There was no difference in ANA between two groups (P>0.05).The NLR levels of 33 patients who received first-line second-generation antipsychotic treatment for 1 month were lower than those at admission (P < 0.05). There were no differences in RDW, hs-CRP and Hcy levels before and after treatment (P>0.05). Logistic regression analysis showed that NLR and age were significantly correlated with abnormal fasting glucose metabolism in patients with recurrence of schizophrenia (OR=1.799, 1.063, respectively, P < 0.05), hs-CRP and age were correlated with abnormal lipid metabolism in patients with recurrent schizophrenia (OR=1.273, 1.031, respectively, P < 0.05).
Conclusion Hcy, hs-CRP, NLR and RDW may play important roles in the pathogenesis of recurrent schizophrenia. The NLR and hs-CRP levels may be related to abnormal glucose and lipid metabolism in patients with recurrent schizophrenia.
- schizophrenia,
- relapse,
- immune inflammation indicators,
- glucose metabolism,
- lipid metabolism,
- blood routine

FullText(HTML)

References (28)

References

[1]	MI W F, CHEN X M, FAN T T, et al. Identifying modifiable risk factors for relapse in patients with schizophrenia in China[J]. Front Psychiatry, 2020, 11: 574763. doi: 10.3389/fpsyt.2020.574763
[2]	PENNINX B W J H, LANGE S M M. Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications[J]. Dialogues Clin Neurosci, 2018, 20(1): 63-73. doi: 10.31887/DCNS.2018.20.1/bpenninx
[3]	LIAO X M, YE H, SI T M. A review of switching strategies for patients with schizophrenia comorbid with metabolic syndrome or metabolic abnormalities[J]. Neuropsychiatr Dis Treat, 2021, 17: 453-469. doi: 10.2147/NDT.S294521
[4]	MONGAN D, RAMESAR M, F?CKING M, et al. Role of inflammation in the pathogenesis of schizophrenia: a review of the evidence, proposed mechanisms and implications for treatment[J]. Early Interv Psychiatry, 2020, 14(4): 385-397. doi: 10.1111/eip.12859
[5]	ENDRES D, LEYPOLDT F, BECHTER K, et al. Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations[J]. Eur Arch Psychiatry Clin Neurosci, 2020, 270(7): 803-818. doi: 10.1007/s00406-020-01113-2
[6]	ORSOLINI L, SARCHIONE F, VELLANTE F, et al. Protein-C reactive as biomarker predictor of schizophrenia phases of illness?A systematic review[J]. Curr Neuropharmacol, 2018, 16(5): 583-606. doi: 10.2174/1570159X16666180119144538
[7]	路钊, 李文标. 同型半胱氨酸与精神分裂症关系及其机制研究进展[J]. 神经疾病与精神卫生, 2019, 19(6): 636-640. doi: 10.3969/j.issn.1009-6574.2019.06.021
[8]	MAZZA M G, LUCCHI S, ROSSETTI A, et al. Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: a meta-analysis and systematic review[J]. World J Biol Psychiatry, 2020, 21(5): 326-338. doi: 10.1080/15622975.2019.1583371
[9]	JAGSCH C, DIETMAIER G, JAGSCH M, et al. Schizophrenia spectrum disorders in elderly patients: Analysis of reasons for admission to a department of geriatric psychiatry[J]. Z Gerontol Geriatr, 2018, 51(2): 206-212. doi: 10.1007/s00391-016-1107-0
[10]	MVLLER N. Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations[J]. Schizophr Bull, 2018, 44(5): 973-982. doi: 10.1093/schbul/sby024
[11]	LIU Y, TAO H, YANG X, et al. Decreased serum oxytocin and increased homocysteine in first-episode schizophrenia patients[J]. Front Psychiatry, 2019, 10: 217. http://www.onacademic.com/detail/journal_1000042322422299_d09c.html
[12]	YVKSEL R N, ERTEK I E, DIKMEN A U, et al. High neutrophil-lymphocyte ratio in schizophrenia independent of infectious and metabolic parameters[J]. Nord J Psychiatry, 2018, 72(5): 336-340. doi: 10.1080/08039488.2018.1458899
[13]	WYSOKINSKI A, SZCZEPOCKA E. Red blood cells parameters in patients with acute schizophrenia, unipolar depression and bipolar disorder[J]. Psychiatr Danub, 2018, 30(3): 323-330. http://archivespp.pl/uploads/images/2017_19_3/16Wysokinski_Archives_PP_3_2017.pdf
[14]	FERNANDES B S, STEINER J, BERNSTEIN H G, et al. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications[J]. Mol Psychiatry, 2016, 21(4): 554-564. doi: 10.1038/mp.2015.87
[15]	KINOSHITA M, NUMATA S, TAJIMA A, et al. Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk[J]. Psychiatry Res, 2016, 246: 833-837. doi: 10.1016/j.psychres.2016.10.017
[16]	KARAGEORGIOU V, MILAS G P, MICHOPOULOS I. Neutrophil-to-lymphocyte ratio in schizophrenia: a systematic review and meta-analysis[J]. Schizophr Res, 2019, 206: 4-12. doi: 10.1016/j.schres.2018.12.017
[17]	ÖZDIN S, BÖKE Ö. Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in different stages of schizophrenia[J]. Psychiatry Res, 2019, 271: 131-135. doi: 10.1016/j.psychres.2018.11.043
[18]	ENDRES D, PERLOV E, FEIGE B, et al. Schizophrenia associated with epileptiform discharges without seizures successfully treated with levetiracetam[J]. Front Psychiatry, 2017, 8: 12. http://europepmc.org/articles/PMC5296318?pdf=render
[19]	VAN MIERLO H C, DE WITTE L, DERKSEN R H, et al. The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study[J]. NPJ Schizophr, 2015, 1: 15013. doi: 10.1038/npjschz.2015.13
[20]	SÆTHER S G, RØ A D B, LARSEN J B, et al. Biomarkers of autoimmunity in acute psychiatric disorders[J]. J Neuropsychiatry Clin Neurosci, 2019, 31(3): 246-253. doi: 10.1176/appi.neuropsych.18040069
[21]	EZEOKE A, MELLOR A, BUCKLEY P, et al. A systematic, quantitative review of blood autoantibodies in schizophrenia[J]. Schizophr Res, 2013, 150(1): 245-251. doi: 10.1016/j.schres.2013.07.029
[22]	李宝琴, 任会鹏, 温洁新, 等. 精神分裂症患者利培酮治疗前后细胞间黏附分子-1等指标的观察[J]. 中国卫生检验杂志, 2014, 24(12): 1725-1728. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ201412017.htm
[23]	张光满, 许华斌, 李莹, 等. 精神分裂症患者血清超敏C反应蛋白水平研究[J]. 蚌埠医学院学报, 2016, 41(10): 1355-1357. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG201610031.htm
[24]	范北方, 李泽辉, 杨硕, 等. 帕利哌酮与利培酮治疗对精神分裂症患者血脂及Hcy代谢、内分泌激素影响的差异[J]. 海南医学院学报, 2017, 23(21): 3036-3038, 3042. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYY201721037.htm
[25]	刁俊荣, 冯玉娇, 宋晓丽, 等. 血清Hcy、BDNF、IGF-2水平与精神分裂症患者临床症状相关性分析[J]. 医学临床研究, 2019, 36(8): 1637-1639. doi: 10.3969/j.issn.1671-7171.2019.08.071
[26]	姚献虎, 夏磊, 李文正, 等. 精神分裂症患者伴发代谢综合征与超敏C反应蛋白水平的相关研究[J]. 中国全科医学, 2020, 23(3): 294-298, 304. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202003010.htm
[27]	李文正, 夏磊, 张雨龙, 等. 慢性精神分裂症血脂代谢特征及其与HS-CRP的关系[J]. 安徽医科大学学报, 2019, 54(12): 1975-1979. https://www.cnki.com.cn/Article/CJFDTOTAL-YIKE201912028.htm
[28]	陈志浩, 赖华生, 温琦, 等. 粒细胞/淋巴细胞比率在代谢综合征中的临床诊断价值[J]. 广东医学, 2015, 36(12): 1930-1932. https://www.cnki.com.cn/Article/CJFDTOTAL-GAYX201512049.htm

[1]	LIN Ningning, ZHAO Jiajia, FAN Junya, TIAN Xinyu, ZHANG Hui. Effects of three therapeutic schedules on cardiac functionand prognosis in patients undergoing percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2022, 26(16): 66-70. DOI: 10.7619/jcmp.20220829
[2]	YANG Junxia. Effect of rehabilitation nursing intervention on the improvement of quality of life in patients with cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2019, 23(12): 96-98, 102. DOI: 10.7619/jcmp.201912028
[3]	DING Xiaowei, CHEN Haiyan. Correlation study of continuous nursing on quality of life in patients with coronary artery disease after transradial coronary intervention[J]. Journal of Clinical Medicine in Practice, 2016, (22): 5-7,14. DOI: 10.7619/jcmp.201622002
[4]	GU Yongzhen. Effect of continuous nursing on the life quality and prognosis in children with asthma[J]. Journal of Clinical Medicine in Practice, 2015, (16): 113-115,119. DOI: 10.7619/jcmp.201516035
[5]	FAN Wenxia, XIAO Qiong, ZHOU Ke. Clinical observation on the effect of nursing intervention on psychologyand quality of life in patients with hemodialysis[J]. Journal of Clinical Medicine in Practice, 2015, (14): 36-38. DOI: 10.7619/jcmp.201514012
[6]	YANG Xiaoping, CHEN Qinjie, LI Lina, CHEN Qing. Quality of life in infertile couples and its influencing factors[J]. Journal of Clinical Medicine in Practice, 2015, (10): 71-74. DOI: 10.7619/jcmp.201510022
[7]	XIANG Mei, LIU Aihua. The impact of high quality nursing on adverse emotion and quality of life in patients with colorectal cancer after operation[J]. Journal of Clinical Medicine in Practice, 2015, (6): 62-64. DOI: 10.7619/jcmp.201506020
[8]	TU Xuemei. The effect and clinical analysis of continuous nursing intervention on prognosis of patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2015, (6): 4-6,22. DOI: 10.7619/jcmp.201506002
[9]	The effect of evidence-based nursing on postoperative complications and life quality of percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2014, (10): 3-5. DOI: 10.7619/jcmp.201410002
[10]	SONG Wenying. Influence of nursing intervention on the quality of life of patients with depression[J]. Journal of Clinical Medicine in Practice, 2013, (16): 147-149. DOI: 10.7619/jcmp.201316057

Cited By

Cited by

Periodical cited type(23)

1.	邓玉珍. 健身气功八段锦锻炼结合睡眠干预对改善冠心病行冠状动脉介入术患者生活质量的效果观察. 心血管病防治知识. 2024(03): 68-72 .
2.	王妍蝶，时贤君，秦庆祝. 认知行为干预结合健康教育对提高冠心病行经皮冠状动脉介入术后患者自我管理能力的效果. 慢性病学杂志. 2024(07): 1017-1020 .
3.	刘翠琴，郭小燕. 基于运动疗法的康复护理对风湿性心脏病瓣膜置换患者术后的影响. 心血管病防治知识. 2024(10): 135-137 .
4.	余媛媛，贺泽霞，张永佳，兰富霞，徐英. 4C干预模式对老年经皮冠状动脉介入术后患者的影响. 实用临床医药杂志. 2023(16): 68-71 . 本站查看
5.	梁夷凤. 冠心病患者PCI术后应用基于5E理念的综合康复护理的效果分析. 中外医疗. 2023(23): 155-159 .
6.	吴伟，高鹃. 双心护理模式对冠心病经皮冠状动脉介入治疗患者心理健康状况和护理满意度的影响观察. 基层医学论坛. 2022(03): 87-89 .
7.	吴张平. 早期心脏康复训练对PCI术后患者的影响. 继续医学教育. 2022(05): 125-128 .
8.	牛杜娟，尚雯，张红. 以FTS理论为指导的系统化护理模式对PCI术后患者心功能的影响. 保健医学研究与实践. 2022(07): 82-85 .
9.	王琳，张亚铮，袁媛. 基于CSMS量表和CQQC的5E康复护理在冠心病PCI术后患者康复中的应用效果. 河北医药. 2022(14): 2228-2231 .
10.	刘娟，刘芳，张静. 临床护理路径在冠状动脉搭桥术患者术后康复中的应用效果研究. 中西医结合心血管病电子杂志. 2022(11): 4-6+13 .
11.	贾艳静，王新宙. 优质护理应用于老年冠心病患者护理中对患者生活质量和疗效的影响. 中国药物与临床. 2021(08): 1409-1411 .
12.	邹蓉蓉，李天兰，吴莉玫，尹艳华. 优化康复护理流程对PCl术后患者心肺功能以及预后的影响分析. 心血管病防治知识. 2021(04): 59-61+64 .
13.	宋敏. 整体化康复护理措施在冠心病患者中的应用. 黑龙江中医药. 2021(01): 294-295 .
14.	张善婷，冯俊，刘洋. 冠心病患者PCI介入治疗中的护患沟通对治疗依从性的影响. 河北医药. 2021(11): 1743-1746 .
15.	胥加艳，郭晓鑫. 5E护理在冠心病病人PCI术后康复中的应用研究. 循证护理. 2021(08): 1108-1111 .
16.	郭秀蝶，郑雅娟，林晨芳，吴群，张亚真. 评判性思维护理对缺铁性贫血伴缺血性心脏病患者贫血及心功能的影响. 心血管病防治知识. 2021(32): 26-29 .
17.	柯晓玲，吴娟娟. 早期康复护理对老年心血管病患者的效果观察. 心血管病防治知识(学术版). 2020(14): 68-70 .
18.	孙婧，李萍. 冠心病患者的系统性心肺康复护理. 实用临床医药杂志. 2020(14): 122-125 . 本站查看
19.	陈燕华，张苗. 慢性肾脏病合并冠心病患者冠状动脉介入术后行血液透析护理研究. 山西医药杂志. 2020(18): 2548-2549 .
20.	刘姝娉. 过渡期康复护理措施对老年心血管疾病患者功能恢复及预后的影响. 心血管病防治知识. 2020(24): 70-72 .
21.	郑燕，常莉，刘桂玲，刘晚霞. 常规护理联合心脏康复护理对冠心病介入治疗后心功能的改善作用. 贵州医药. 2020(10): 1662-1663 .
22.	张书明. 探讨冠心病冠状动脉介入术患者心脏康复护理模式的建立对促进患者术后恢复的意义. 心血管病防治知识. 2020(31): 58-60 .
23.	聂志鑫. 时机理论下的家庭护理对经皮冠状动脉性心脏病介入治疗后患者预后和生活质量的影响. 中西医结合护理(中英文). 2020(11): 59-62 .

Other cited types(0)

Get Citation

PDF

XML

Article views (337) PDF downloads (16) Cited by(23)

Turn off MathJax

Article Contents

Abstract

References

Relationship between expression of immune inflammationindicators and abnormal glucose as well as lipid metabolism in patients with recurrent schizophrenia

Abstract

References

Related Articles

Cited by

Periodical cited type(23)

Other cited types(0)

Catalog

Relationship between expression of immune inflammationindicators and abnormal glucose as well as lipid metabolism in patients with recurrent schizophrenia

Abstract

References

Related Articles

Cited by

Periodical cited type(23)

Other cited types(0)

Catalog

Export File

Citation

Format

Content